title: Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
authors.affiliation: Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, Michigan, USA.
authors.forename: Suna
authors.initials: S
authors.lastname: Yapali
authors.affiliation: Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, Michigan, USA.
authors.forename: Anna S
authors.initials: AS
authors.lastname: Lok
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular; D005260:Female; D019694:Hepatitis B, Chronic; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms; D008297:Male; D062072:Patient Acuity
chemical_list: D000998:Antiviral Agents
keywords: Antiviral Therapy; Cirrhosis; Hepatitis B; Hepatocellular Carcinoma